COVID-19 Across The UAE - Daily Update (May 28, 2020)

While March 2020 may seem like a distant memory, courts across the country are still busy hearing cases related to the COVID-19 pandemic.

As we previously reported, New York's COVID-19 Sick Leave Law (amending N.Y. Lab. L. §196-b) will expire on July 31, 2025.

Nurses make up the largest section of the healthcare profession and spend more time with patients than any other care team member.

In August 2021, the U.S. Secretary of Defense mandated that all service members receive the COVID-19 vaccine. The policy was later rescinded in January 2023, but not before thousands of service members were separated...

Last week, the North Carolina Supreme Court issued its long-awaited ruling in North State Deli, LLC v. The Cincinnati Insurance Company, siding with a group of North Carolina restaurants...

It goes without saying that COVID was an extremely challenging period. And while the emergence from the depths of lockdowns, facemasks and constant hand sanitizer...

Recently, there has been a significant increase in scams targeting users of the System for Award Management (SAM.gov).

The United States District Court for the District of Rhode Island cast a spotlight on the doctrine of implied waiver of attorney-client privilege in a recent False Claims Act ("FCA") case.

During the COVID-19 pandemic, the District of Columbia, like many jurisdictions, extended statutes of limitations by Administrative Orders of the D.C. Superior Court.

The Department of Justice (DOJ) continues to demonstrate its sustained interest in COVID-19 relief fraud as an enforcement priority and we can expect to see persistent enforcement in this area.

Expands Defense Production Act (DPA; P.L. 81-774) authorities over energy by giving the Secretaries of the Interior and Energy independent authority, alongside the Secretary of Commerce...

Directs the Department of War and Department of Veterans Affairs to establish continuous sharing of military personnel and medical records, deploy AI-enabled tools to streamline veterans...

President Trump's executive order directs multiple federal agencies to comprehensively review policies affecting American cattle ranchers, including potential wolf delisting under the Endangered Species Act and mandatory country-of-origin labeling for beef products. The order aims to develop actionable recommendations to enhance rancher profitability and expand market access for domestic beef producers.

On July 22, 2026, the Federal Communications Commission (FCC or Commission) adopted a Third Report and Order and Third Further Notice of Proposed Rulemaking (covered separately here) in which the Commission advances its ongoing efforts to secure the U.S.

California's Legislature has unanimously passed SB 690, a landmark reform that could eliminate thousands of pending class action lawsuits based on website tracking technologies under the California Invasion of Privacy Act. The bill removes the private right of action for pen register claims arising from routine web analytics tools, potentially reshaping the data privacy litigation landscape while companion bills simultaneously expand substantive privacy obligations.

On September 3, 2026, the Securities and Exchange Commission (SEC or Commission) announced its plan to rescind Rule 206(4)-5 under the Investment Advisers Act of 1940, as amended, also known as the “Pay-to-Play Rule” (the Rule), which has been in effect since 2010.

Last week, Congress officially kicked the FY 2027 funding can down the road. The House overwhelmingly approved the Senate's bipartisan continuing resolution by a 370-48 vote...

The Protect College Sports Act of 2026 (PCSA), introduced in the Senate on June 2, 2026, by Senators Ted Cruz (R-TX) and Maria Cantwell (D-WA) and joined by Senators Eric Schmitt (R-MO) and Chris Coons (D-DE), represents a comprehensive federal legislative effort to reshape the governance and economics of intercollegiate athletics...

On September 1, 2026, the Food & Drug Administration (FDA) reinforced its prior conclusion that fluoropolymers used in medical devices are safe and materially different from the per- and polyfluoroalkyl substances (PFAS) that drive most regulatory, litigation and public health concerns

The U.S. Court of Appeals for the Eleventh Circuit issued its much-anticipated decision in United States ex rel. Zafirov v. Florida Medical Associates, LLC, No. 24-13581, holding that the qui tam provisions of the FCA do not violate the Appointments Clause of Article II of the U.S. Constitution.